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1. Introduction 
 Chemogenomics aims to discover active and/or selective ligands for biologically related 
targets by conducting screening, ideally, of all possible compounds against all possible targets, 
or at least, in practice, available libraries of compounds against main target families [1]. One can 
hardly imagine to screen experimentally the chemical universe containing from 10
12
 to 10
180
 
druglike compounds [2] against biological target universe. While the number of compounds that 
can be screened in the course of high-throughput screening experiments can hardly be imagined 
to exceed several millions per biological target even in the largest pharmaceutical corporations, 
the number of molecules that can be screened in silico in a single non-expensive computational 
study currently reaches 10
12
, and this number can grow sharply in the nearest future. Therefore, 
the virtual, or in silico, screening approaches play a key role in chemogenomics. 
 Virtual screening is usually defined as a process in which large libraries of compounds 
are automatically evaluated using computational techniques [3]. Its goal is to discover putative 
hits in large databases of chemical compounds (usually ligands for biological targets) and 
remove molecules predicted to be toxic or those possessing unfavorable pharmacodynamic or 
pharmacokinetic properties. Generally, two types of virtual screening are known: structure-based 
and ligand-based. The former explicitly uses 3D structure of a biological target at the stage of hit 
detection, whereas the latter uses only information about structure of small molecules and their 
properties (activities), see [4-6] and references therein. Structure-based virtual screening 
(docking, 3D pharmacophores) has been described in series of review articles, see [7-9] and 
references therein.  
 In this paper mostly ligand-based virtual screening involving fragment descriptors is 
considered. Fragment descriptors, represent selected substructures (fragments) of 2D molecular 
graphs and their occurrences in molecules; they constitute one of the most important types of 
molecular descriptors [10]). Their main advantage is related to simplicity of their calculation, 
storage and interpretation (see review articles [11-15] and book chapter [16]). From the 
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mathematical point of view, they constitute a basis of invariants of labeled molecular graphs, and 
therefore any molecular property and any similarity measure for molecular graphs can be 
expressed through them [17-19]. Fragment descriptors are information-based ones [20] which 
tend to code the information stored in molecular structures. This contrasts with knowledge-based 
(or semiempirical) descriptors issued from the consideration of the mechanism of action. 
Selected descriptors form a “chemical space” in which each molecule is represented as a vector 
[21]. Due to their versatility, fragment descriptors could be efficiently used to create a chemical 
space which separates active and non-active compounds.  
Historically, molecular fragments were used in first additive schemes developed in 1950-
ies to estimate physicochemical properties of organic compounds by Tatevskii [22, 23], 
Bernstein [24], Laidler [25], Benson and Buss [26] and others. The Free-Wilson method [27], 
one of the first QSAR approaches invented in 1960-ies, is based on the assumption of the 
additivity of contributions of structural fragments to the biological activity of the whole 
molecule. Later on, fragment descriptors were successfully used in expert systems able to 
classify chemical compounds as active or inactive with respect to certain type of biological 
activity. Hiller [28, 29], Golender and Rosenblit [30, 31], Piruzyan, Avidon et al [32, 33], 
Cramer [34], Brugger, Stuper and Jurs [35, 36], and Hodes et al [37] pioneered in this field. 
An important class of fragmental descriptors, so-called screens (structural keys, fingerprints), 
has been developed in seventies [38-42]. As a rule, they represent bit strings which can 
effectively be stored and processed by computers. Although their primary role is to provide 
efficient substructure searching capabilities in large chemical databases, they are efficiently used 
for similarity searching [43, 44], to cluster large data sets [45, 46], to assess chemical diversity 
[47], as well as to conduct SAR [48] and QSAR [49] studies. Nowadays, application of modern 
machine-learning techniques significantly improves predictive performance of structure-property 
models based on fragment descriptors [50]. 
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This paper briefly reviews the application of fragment descriptors in virtual screening of 
large libraries of organic compounds focusing mostly on its three approaches: (i) filtering, (ii) 
similarity search, and (iii) direct activity/property assessment using QSAR/QSPR models.  
 
2. Types of fragment descriptors 
 Due to their enormous diversity, one could hardly review all types of 2D fragment 
descriptors used for structural search in chemical database or in SAR/QSAR/QSPR studies. 
Here, we focus on some of them which are the most efficiently used in virtual screening and in 
silico design of organic compounds. 
Generally, molecular fragments can be classified with respect to their topology (atom-
based, chains, cycles, polycycles, etc), information content of vertices in molecular graphs 
(atoms, groups of atoms, pharmacophores, descriptor centers) and the level of abstraction when 
some information concerning atom and bond types is omitted.  
 Purely structural fragments are used as descriptors in ACD/Labs [51], NASAWIN [52], 
ISIDA [15] and some other programs. These are 2D subgraphs in which all atoms and/or bonds 
are represented explicitly and no information about their properties is used. Their typical 
examples are the sequences of atoms and/or bonds of variable length, branch fragments, 
saturated and aromatic cycles (polycycles) and atom-centered fragments (ACF). The latter 
consist of a single central atom surrounded by one or several shells of atoms with the same 
topological distance from the central one. The ACF were invented by Tatevskii [22] and Benson 
and Buss [26] in 1950-ies as elements of additive schemes for predicting physicochemical 
properties of organic compounds. In earlier seventies, Adamson [53] investigated the distribution 
of one shell ACF in some chemical databases with respect to their possible application as 
screens. Hodes reinvented one shell ACF as descriptors in SAR studies under the name 
augmented atoms [37], and also suggested ganglia augmented atoms [54] representing two shells 
ACF with generalized second-shell atoms. Later on, one shell ACF were implemented by Baskin 
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et al in the NASAWIN [52] software and by Varnek et al in ISIDA [15, 55] package. Atom-
centered fragments with arbitrary number of shells were implemented by Poroikov et al in the 
PASS [56] program under the name multilevel neighborhoods of atoms [57], by Xing and Glen 
under the name tree structured fingerprints [58] (sometimes referred to by Bender, Glen et al as 
atom environments [59, 60] and circular fingerprints [61-63]), and by Faulon under the name 
molecular signatures [64-66]. 
 It has been found that characterizing atoms only by element types is too specific for 
similarity searching and therefore doesn’t provide sufficient flexibility needed for large-scaled 
virtual screening. For that reason, numerous studies were devoted to increase an informational 
content of fragment descriptors by adding some useful empirical information and/or by 
representing a part of molecular graph implicitly. The simplest representatives of those 
descriptors were atom pairs and topological multiplets based on the notion of descriptor center 
representing an atom or a group of atoms which could serve as centers of intermolecular 
interactions. Usually, descriptor centers include heteroatoms, unsaturated bonds and aromatic 
cycles. An atom pair is defined as a pair of atoms (AT) or descriptor centers separated by a fixed 
topological distance: ATi-ATj-Dist, where Distij is the shortest path (the number of bonds) 
between ATi and ATj. Analogously, a topological multiplet is defined as a multiplet (usually 
triplet) of descriptor centers and topological distances between each pair of them. In most of 
cases, these descriptors are used in binary form in order to indicate the presence or absence of 
the corresponding features in studied chemical structures.  
 The atom pairs were first suggested for SAR studies by Avidon under the name SSFN 
(Substructure Superposition Fragment Notation) [33, 67]. Then they were independently 
reinvented by Carhart and co-authors [68] for similarity and trend vector analysis. In contrast to 
SSFN, Carhart’s atom pairs are not necessarily composed only of descriptor centers, but account 
for the information about element type, the number of bonded non-hydrogen neighbors and the 
number of π electrons. Nowadays, Carhart’s atom pairs are rather popular for conducting virtual 
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screening. Modified Carharts’s atom pairs, in which descriptors centers are represented by atoms 
coded with the help of a hierarchical classification scheme [52], have recently been used in 
virtual screening based on the one-class classification technique [69]. Topological Fuzzy Bipolar 
Pharmacophore Autocorrelograms (TFBPA) [70] by Horvath are based on atom pairs, in which 
real atoms are replaced by pharmacophore sites (hydrophobic, aromatic, hydrogen bond 
acceptor, hydrogen bond donor, cation, anion), while Distij corresponds to different ranges of 
topological distances between pharmacophores. These descriptors were successfully applied in 
virtual screening against a panel of 42 biological targets using similarity search based on several 
fuzzy and non-fuzzy metrics [71], performing only slightly less well than their 3D counterparts 
[70].  
Fuzzy Pharmacophore Triplets (FPT) by Horvath [72] is an extention of (Fuzzy Bipolar 
Pharmacophore Fingerprints) FBPF [71] for three sites pharmacophores. An important 
innovation in the FPT concerns accounting for proteolytic equilibrium as a function of pH [72]. 
Due to this feature, even small structural modifications leading to a pKa shift, may have a 
profound effect on the fuzzy pharmocophore triples. As a result, these descriptors efficiently 
discriminate structurally similar compounds exhibiting significantly different activities [72]. 
 Some other topological triplets should be mentioned. Thus, Similog pharmacophoric keys 
by Jacoby [73] represent triplets of binary coded types of atoms (pharmacophoric centers) and 
topological distances between them. Atomic types are generalized by four features (represented 
as four bits per atom): potential hydrogen bond donor or acceptor; bulkiness and 
electropositivity. The topological pharmacophore-point triangles implemented in the MOE 
software [74] represent triplets of MOE atom types separated by binned topological distances. 
Structure-property models obtained by support vector machine method with these descriptors 
have been successfully used for virtual screening of COX-2 inhibitors [75] and D3 dopamine 
receptor ligands [76].  
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 Topological torsions by Nilakantan et al [77] is a sequence of four consecutively bonded 
atoms ATi-ATj-ATk-ATl, where each atom is characterized by a number of parameters similarly 
to atoms in Carhart’s pairs. In order to enhance efficiency of virtual screening, Kearsley et al 
[78] suggested to assign atoms in the Carhart’s atom pairs and Nilakantan’s topological torsions 
to one of seven classes: cations, anions, neutral hydrogen bond donors, neutral hydrogen bond 
acceptors, polar atoms, hydrophobic atoms and other.  
 In the frameworks of the Simplex representation of molecular structure (SiRMS) by 
Kuz’min et al [79] any molecule can be represented as an ensemble of different 4-atomic 
fragments - simplexes. The occurrence number of identical simplexes in a molecule is a 
descriptor value. Subgraphs corresponding to simplexes can be either connected or disconnected. 
Not only atom type, but also some other physical-chemical characteristics of atoms (partial 
charge, lipophilicity, refraction and atom's ability for being a donor/acceptor in hydrogen-bond 
formation, etc) can be used for atom labeling. Fragment descriptors based on SiRMS were used 
for building QSAR models and performing virtual screening and molecular design of compounds 
with strong antiviral activity [80]. 
 ISIDA Property-Labeled Fragment Descriptors (IPLF) were introduced as counts of 
specific subgraphs in which atom vertices are colored with respect to some local property [81]. 
Various coloring strategies (notably pH-dependent pharmacophore and electrostatic potential-
based flagging) can be combined in the framework of this approach with various fragmentation 
schemes (chains, atom pairs, augmented atoms, trees, etc). IPLF showed excellent results in 
similarity-based virtual screening for analogue protease inhibitors and in building highly 
predictive octanol-water partition coefficient and hERG channel inhibition models [81]. IPLF 
were also advantageously used in combination with the Generative Topographic Mapping 
(GTM) method for chemical space visualization, structure-activity modeling and database 
comparison [82]. 
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In contrast to QSPR studies based mostly on the use of complete (containing all atoms) or 
hydrogen-suppressed molecular graphs, handling biological activity at the qualitative level, often 
demands more abstractions. Namely, it is rather convenient to approximate chemical structures 
by reduced graphs, in which each vertex is an atom or a group of atoms (descriptor or 
pharmacophoric center), whereas each edge is a topological distance Distij. Such biology-
oriented representation of chemical structures was suggested by Avidon et al as descriptor center 
connection graphs [33]. Gillet, Willett and Bradshaw have proposed the GWB-reduced graphs 
which use the hierarchical organization of vertex labels. This allows one to control the level of 
their generalization which may explain their high efficiency in similarity searching. 
 
3. Application of fragment descriptors in virtual screening and in silico design 
 In this chapter application of fragment descriptors at different stages of virtual screening 
is considered.  
 
3.1. Filtering 
 Filtering is a rule-based approach aimed to perform fast assessment of usefulness 
molecules in the given context. In drug design area, the filtering is used to eliminate compounds 
with unfavorable pharmacodynamic or pharmacokinetic properties as well as toxic compounds. 
Pharmacodynamics considers binding drug-like organic molecules (ligands) to chosen biological 
target. Since the efficiency of ligand-target interactions depends on spatial complementarity of 
their binding sites, the filtering is usually performed with 3D-pharmacophores, representing 
“optimal” spatial arrangements of steric and electronic features of ligands [83, 84]. 
Pharmacokinetics is mostly related to absorption, distribution, metabolism and excretion 
(ADME) related properties: octanol-water partition coefficients (log P), solubility in water (log 
S), blood-brain coefficient (log BB), partition coefficient between different tissues, skin 
penetration coefficient, etc.  
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 Fragment descriptors are widely used for early ADME/Tox prediction both explicitly and 
implicitly. The easiest way to filter large databases concerns detecting undesirable molecular 
fragments (structural alerts). Appropriate lists of structural alerts are published for toxicity [85], 
mutagenicity [86], and carcinogenicity [87]. Klopman et al were the first to recognize the 
potency of using fragmental descriptors for this purpose [88-90]. Their programs CASE [88], 
MultiCASE [91, 92], as well as more recent MCASE QSAR expert systems [93], proved to be 
effective tools to assess mutagenicity [89, 92, 93] and carcinogenicity [90, 92] of organic 
compounds. In these programs, sets of biophores (analogs of structural alerts) were identified 
and used for activity predictions. A number of more sophisticated fragment-based expert systems 
of toxicity assessment - DEREK [94], TopKat [95] and Rex [96] – have been developed. 
DEREK is a knowledge-based system operating with human-coded or automatically generated 
[97] rules about toxicophores. Fragments in the DEREK knowledge base are defined by means 
of linear notation language PATRAN which codes the information about atom, bonds and 
stereochemistry. TopKat uses a large predefined set of fragment descriptors, whereas Rex 
implements a special kind of atom-pairs descriptors (links). To read more information about 
fragment-based computational assessment of toxicity, including mutagenicity and 
carcinogenicity, see review [98] and references therein. 
 The most popular filter used in drug design area is based on the Lipinsky “rule of five” 
[99], which takes into account the molecular weight, the number of hydrogen bond donors and 
acceptors, along with the octanol-water partition coefficient logP, to assess the bioavailability of 
oral drugs. Similar rules of “drug-likeness” or “lead-likeness” were later proposed by by Oprea 
[100], Veber [101] and Hann [102]. Formally, fragment descriptors are not explicitly involved 
there. However, many computational approaches to assess logP are fragment-based [51, 103, 
104]; wheras H-donors and acceptor sites are simplest molecular fragments.  
  
3.2. Similarity search 
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The similarity-based virtual screening is based on an assumption that all compounds in a 
chemical database, which are similar to a query compound, could also have similar biological 
activity. Although this hypothesis is not always valid (see discussion in [105]), quite often the set 
of retrieved compounds is enriched by actives [106].  
To achieve high efficacy of similarity-based screening of databases containing millions 
compounds, molecular structures are usually represented by screens (structural keys) or fixed-
size or variable-size fingerprints. Screens and fingerprints can contain both 2D- and 3D-
information. However, the 2D-fingerprints, which are a kind of binary fragment descriptors, 
dominate in this area. Fragment-based structural keys, like MDL keys [48], are sufficiently good 
for handling small and medium-sized chemical databases, whereas processing of large databases 
is performed with fingerprints having much higher information density. Fragment-based 
Daylight [107], BCI [108] and UNITY 2D [109] fingerprints are the most known examples.  
 The most popular similarity measure for comparing chemical structures represented by 
means of fingerprints is the Tanimoto (or Jaccard) coefficient T [110]. Two structures are usually 
considered similar if T>0.85 [106] (for Daylight fingerprints [107]). Using this threshold, Taylor 
estimated a probability to retrieve actives as 0.012-0.50 [111], whereas according to Delaney this 
number raises to 0.40-0.60 [112] (using Daylight fingerprints [107]). These computer 
experiments confirm usefulness of the similarity approach as an instrument of virtual screening. 
 Schneider et al have developed a special technique for performing virtual screening 
referred to as CATS (Chemically Advanced Template Search) [113]. In its framework chemical 
structures are described by means of so-called correlation vectors, each component of which 
equals to the number of times a certain atom pair is contained in a chemical structure divided by 
the total number of non-hydrogen atoms in it. Each atom in an atom pair is specified as 
belonging to one of five classes (hydrogen-bond donor, hydrogen-bond acceptor, positively 
charged, negatively charged, and lipophilic), while topological distances of up to 10 bonds are 
also considered in the atom-pair specification. The similarity between molecules is assessed in 
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this approach using Euclidean distance between the corresponding correlation vectors. CATS 
was shown to outperform MERLIN with Daylight fingerprints [107] for retrieving thrombin 
inhibitors in a virtual screening experiment [113]. 
 Hull et al have developed the Latent Semantic Structure Indexing (LaSSI) approach to 
perform similarity search in low-dimensional chemical space [114] [115]. To reduce the 
dimension of initial chemical space, the singular value decomposition method is applied for the 
descriptor-molecule matrix. Ranking molecules by similarity to a query molecule was performed 
in the reduced space using the cosine similarity measure [116], whereas the Carhart’s atom pairs 
[68] and the Nilakantan’s topological torsions [77] were used as descriptors. The authors claim 
that this approach “has several advantages over analogous ranking in the original descriptor 
space: matching latent structures is more robust than matching discrete descriptors, choosing the 
number of singular values provides a rational way to vary the ‘fuzziness’ of the search” [114].  
 The issue of “fuzzification” of similarity search was addressed by Horvath et al [70-72]. 
The first fuzzy similarity metric suggested in work [70] relies on partial similarity scores 
calculated with respect to the inter-atomic distances distributions for each pharmacophore pair. 
In this case the “fuzziness” enables to compare pairs of pharmacophores with different 
topological or 3D distances. Similar results [71] were achieved using fuzzy and weighted 
modified Dice similarity metric [116]. Fuzzy pharmacophore triplets FPT (see section 2) can be 
gradually mapped onto related basis triplets, thus minimizing binary classification artifacts [72]. 
In new similarity scoring index introduced in reference [72], the simultaneous absence of a 
pharmacophore triplet in two molecules is taken into account. However, this is a less-
constraining indicator of similarity than simultaneous presence of triplets. 
 Most of similarity search approaches require only a single reference structure. However, 
in practice several compounds with the same type of biological activity are often available. This 
motivated Hert et al [117] to develop the data fusion method which allows one to screen a 
database using all available reference structures. Then, the similarity scores are combined for all 
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retrieved structures using selected fusion rules. Searches conducted on the MDL Drug Data 
Report database using fragment-based UNITY 2D [109], BCI [108], and Daylight [107] 
fingerprints have proved the effectiveness of this approach. 
 The main drawback of the conventional similarity search concerns an inability to use 
experimental information on biological activity to adjust similarity measures. This results in 
inability to discriminate between relevant and non-relevant fragment descriptors being used for 
computing similarity measures. To tackle this problem, Cramer et al [34] developed 
substructural analysis in which each fragment (represented as a bit in a fingerprint) is weighted 
by taking into account its occurrence in active and in inactive compounds. Later on, many 
similar approaches have been described in the literature [118].  
 One-class classification [119] (or novelty detection [120, 121]) is a novel promising 
approach to conducting similarity-based virtual screening. It considers two types of compounds: 
active (“object class”) and inactive (“outliers”). A new compound is predicted to be active if it 
lies in the dense area of the point cloud formed by active compounds contained in the training set 
and inactive if outside. Thus, this new compound is viewed as being similar to the set of active 
compounds. The fundamental difference between the one-class classification and the 
conventional similarity search is the ability of the former to use the whole training set instead of 
a single query compound in order to learn the optimal similarity measure for virtual screening. In 
accordance with this methodology, Karpov et al [69, 122] used the auto-associative neural 
networks and the one-class Support Vector Machines (1-SVM) in virtual screening (using 
fragment descriptors) against various biological targets. 
 One more way to conduct a similarity-based virtual screening is to retrieve the structures 
containing a user-defined set of “pharmacophoric” features. In Dynamic Mapping of Consensus 
positions (DMC) algorithm [123] those features are selected by finding common positions in bit 
strings for all active compounds. The potency-scaled DMC algorithm (POT-DMC) [124] is a 
modification of DMC in which compounds activities are taken into account. The latter two 
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methods may be considered as intermediate between conventional similarity search and 
probabilistic SAR approaches. 
 Batista, Godden and Bajorath developed the MolBlaster method [125], in which 
molecular similarity is assessed by Differential Shannon Entropy [126] computed from 
populations of randomly generated fragments. For the range 0.64 < T < 0.99, this similarity 
measure provides with the same ranking as the Tanimoto index T. However for the smaller 
values of T the entropy-based index is a more sensitive, since it distinguishes between pairs of 
molecules having almost identical T. To adapt this methodology for large-scale virtual screening, 
the Proportional Shannon Entropy (PSE) metrics was introduced [127]. A key feature of this 
approach is that class-specific PSE of random fragment distributions enables the identification of 
the molecules sharing with known active compounds a significant number of signature 
substructures.  
 Similarity search methods developed for individual compounds are difficult to apply 
directly for chemical reactions involving many species subdividing by two types: reactants and 
products. To overcome this problem, Varnek et al [15] suggested to condense all participating in 
reaction species in one only molecular graph (Condensed Graphs of Reactions (CGR) [15]) 
followed by its fragmentation and application of developed fingerprints in “classical” similarity 
search. Besides conventional chemical bonds (simple, double, aromatic, etc), a CGR contains 
dynamical bonds corresponding to created, broken or transformed bonds. This approach could be 
efficiently used for screening of large reaction databases.   
 It should be noted that the similarity concepts are widely used in selecting of diverse sets 
of compounds (see reviews [128-132] and references therein).  
 
3.3. SAR/QSAR/QSPR models 
 Simplistic and heuristic similarity-based approaches can hardly produce as good 
predictive models as modern statistical and machine learning methods able to assess 
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quantitatively biological or physicochemical properties [50]. QSAR-based virtual screening 
consists in direct assessment of activity values (numerical or binary) of all compounds in the 
database followed by selection of hits possessing desirable activity. Mathematical methods used 
for models preparation could be subdivided into probabilistic and regression approaches. The 
former assesses a probability that a given compound is active or not active whereas the latter 
numerically evaluate the activity values. A limited size of this paper doesn’t allow us to cite all 
successful stories related to application of probabilistic and regression models in virtual 
screening; only some examples will be presented. 
 Harper et al [133] have demonstrated a much better performance of probabilistic binary 
kernel discrimination method to screen large databases compared to backpropagation neural 
networks or conventional similarity search. The Carhart’s atom-pairs [68] and Nilakantan’s 
topological torsions [77] were used as descriptors in that study. 
Aiming to discover new cognition enhancers, Geronikaki et al [134] applied the PASS 
program [56], which implements a probabilistic Bayesian-based approach, and the DEREK rule-
based system [94] to screen a database of highly diverse chemical compounds. Eight compounds 
with the highest probability of cognition-enhancing effect were selected. Experimental tests have 
shown that all of them possessed a pronounced antiamnesic effect.  
Bender, Glen et al have applied [59-63] several probabilistic machine learning methods 
(naïve Bayesian classifier, inductive logic programming, and support vector inductive learning 
programming) in conjunction with circular fingerprints for making classification of bioactive 
chemical compounds and performing virtual screening on several biological targets. The latter of 
these three methods (i.e. support vector inductive learning programming) was shown to perform 
significantly better than the other two methods [63]. Advantages of using circular fingerprints 
were pointed out [61]. 
Regression QSAR/QSPR models are used to assess ADME/Tox properties or to detect 
“hit” molecules capable to bind a certain biological target. Available in the literature fragments 
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based QSAR models for blood-brain barrier [135], skin permeation rate [136], blood-air [137] 
and tissue-air partition coefficients [137] could be mentioned as examples. Many theoretical 
approaches of calculation of octanol/water partition coefficient log P involve fragment 
descriptors. The methods by Rekker [138, 139], Leo and Hansch (CLOGP) [103, 140], Ghose-
Crippen (ALOGP) [141-143], Wildman and Crippen [144], Suzuki and Kudo (CHEMICALC-2) 
[145], Convard (SMILOGP) [146], Wang (XLOGP) [147, 148] represent just a few modern 
examples. Fragment-based predictive models for estimation solubility in water [149] and DMSO 
[149] are available. 
Benchmarking studies performed in references [135-137, 150] show that QSAR/QSPR 
models for various biological and physicochemical properties involving fragment descriptors are, 
at least, as robust as those involving topological, quantum, electrostatic and other types of 
descriptors.  
 
3.4. In silico design 
 In this section we consider examples of virtual screening performed on a database 
containing only virtual (still non-synthesized or unavailable) compounds. Generation of virtual 
libraries is usually performed using combinatorial chemistry approaches [151-153]. One of 
simplest ways is to attach systematically user-defined substituents R1, R2, …, RN to a given 
scaffold. If the list for the substituent Ri contains ni candidates, the total number of generated 
structures is N = 
i
in , although taking symmetry into account could reduce the library’s size. 
The number of substituents Ri (ni) should be carefully selected in order to avoid a generation of 
too large set of structures (combinatorial explosion). The “optimal” substituents could be 
prepared using fragments selected at the QSAR stage, since their contributions into activity (for 
linear models) allow one to estimate an impact of combining the fragment into larger species 
(Ri). In such a way, a focused combinatorial library could be generated.   
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 The technology based on combining QSAR, generation of virtual libraries and screening 
stages has been implemented into ISIDA program and applied to computer-aided design of new 
uranyl binders belonging to two different families of organic molecules: phosphoryl containing 
podands [154] and monoamides [155] . QSAR models have been developed using different 
machine-learning methods (multi-linear regression analysis, associative neural networks [156] 
and support vector machines [157]) and fragment descriptors (atom/bond sequences and 
augmented atoms). Then, these models were used to screen virtual combinatorial libraries 
containing up to 11000 compounds. Selected hits were synthesized and tested experimentally. 
Experimental data well correspond to predicted the uranyl binding affinity. Thus, initial data sets 
were significantly enriched with new efficient uranyl binders, and one of new molecules was 
found more efficient than previously studied compounds.  A similar study was conducted for 
development of new 1-[2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) derivatives 
potentially possessing high anti-HIV activity [158]. This demonstrates universality of fragment 
descriptors and broad perspectives of their use in virtual screening and in silico design. 
 
Conclusion 
 The power of fragment descriptors originates from their universality, very high 
computational efficacy, simplicity of interpretation, as well as their high diversity and versatility. 
The latest challenges in chemogenomics and high throughput virtual screening have raised their 
role in effective processing of huge amounts of relevant data and computer-aided design of new 
compounds. 
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